September 5, 2018 – Life sciences recruitment firm GeneCoda has formed an advisory board to assist in implementing its plans and identifying future growth opportunities.
The advisory board is charged with providing advice, recommendations and guidance to the firm’s board of directors and management.
The initial appointments are Peter C. Johnson, John Campbell and Barry Buzogany.
“We are extraordinarily proud to have these leading experts with diverse experiences in drug development, operational leadership, corporate development and business growth on our advisory board,” said Don Alexander, GeneCoda president and managing director. “With experience working directly for and serving dozens of companies in the life sciences industry, Peter, Barry and John will use their respective talents to help us realize our potential as a leading executive and professional search firm focusing on the life sciences industry.”
Dr. Johnson is a graduate of the University of Notre Dame and SUNY Upstate Medical University. After general and plastic surgery training, Dr. Johnson practiced reconstructive surgery for ten years at the University of Pittsburgh School of Medicine, where he founded and was the first president of the Pittsburgh Tissue Engineering Initiative. Subsequent roles included co-founder/CEO of Tissue Informatics; EVP of Life Science; CMO and CBO of Icoria; EVP, Entegrion Inc.; and VP, research and development and medical and scientific affairs of Vancive Medical Technologies, an Avery Dennison business.
|Check out our latest upload from GeneCoda|
Dr. Johnson currently serves as president and CEO of Scintellix and co-founding principal of MedSurgPI, which provides novel, commercially-focused medical affairs services for pharmaceutical, biotechnology, medical device and related technology companies and institutions.
John Campbell is a human resources and talent management leader with over 25 years of experience in Fortune 500 organizations. Mr. Campbell has spent his career focused on enabling organizations to achieve greater HR sophistication and market leadership through people practices that are simple and effective for the needs of a particular organization, said GeneCoda. He has led HR, talent acquisition and talent development functions within such companies as Cree, Quintiles, American Express, LabCorp and Pepsi.
As the founder and principal consultant of Talent Outcomes, a human resources and talent consultancy, Mr. Campbell now focuses on helping small business owners maximize their investment in their talent. He earned a master’s degree in industrial and labor relations, and a bachelor’s in journalism, from West Virginia University.
Mr. Buzogany has been a corporate attorney and C-suite executive (CEO/COO/CLO) for the past 30 years with both public and private life sciences and pharmaceutical companies, ranging in size from early stage to multinationals. He has held executive positions at Battelle Memorial Institute, Boehringer Ingelheim Pharma, Novo Nordisk, Centocor and Gene Logic. Recent past companies include Icoria (formerly Paradigm Genetics), then a publicly traded biotech in Research Triangle Park, NC, where he served as vice president and general counsel before being named chief operating officer; and president & CEO of Jenken Biosciences, an early stage drug development company. He currently serves as a professional board director, business consultant and mentor to several healthcare-related technology companies. He has also served as a program speaker and panelist on the topic of the professional job search process.
Talent Leadership Reports
Hunt Scanlon has been publishing industry studies for more than 25 years and our Talent Leadership Reports are now standard reading material for executive recruiters and their corporate talent acquisition counterparts. Become an underwriting sponsor in 2018.
GeneCoda, based in Wake Forest, NC, was launched earlier this year. It focuses on U.S. recruitment with emphasis on the life sciences sector, including pharmaceutical, biotechnology, medical device and diagnostic innovators and the service sector and tools companies that support them in bringing products to market.
Mr. Alexander has over 15 years of progressive executive search experience and has made hundreds of placements in the life sciences sector. Among other achievements, he is credited with having built Arris Partners’ life sciences practice. Earlier in his career, Mr. Alexander spent time with MATRIX Resources and Renaissance Worldwide.
The name GeneCoda is a combination of the words Genesis (origin) and Coda (conclusion), translating to “start and finish.” As part of its foundation, one of GeneCoda’s main objectives will be its search completion rate as measured against its peers, said Mr. Alexander, who is president and managing director of the firm.
“Our life sciences clients want to work with seasoned professionals who know how to plan and execute an effective search strategy in the highly competitive life sciences industry,” said Mr. Alexander. “Too often, because of the challenges involved in our field, search firms don’t put the ball in the end zone. We do.”
“My philosophy is that service-sector firms are all about their people,” he said. “It’s not about the firm and, in the end, it’s about the results of the people we place. To think that we might place a professional who discovers a cure or moderates ‘X’ disease is more than enough reason for me to get to work.”
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; Stephen Sawicki, Managing Editor; and Andrew W. Mitchell, Managing Editor – Hunt Scanlon Media